Atlas Trials

Selection and Efficacy-Influencing Factors of First-Line Biologic Agents in Moderate-to-Severe Ulcerative Colitis

Clinical trial NCT06962020 · RECRUITING

Trial details

NCT number
NCT06962020
Sponsor
Xijing Hospital of Digestive Diseases
Status
RECRUITING
Study type
OBSERVATIONAL
Ulcerative Colitis (UC)
Start date
2025-04-30
Primary completion
2025-11-20
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.